Last reviewed · How we verify

NCT04476823

European Pathology Laboratories and COVID-19

Completed Last updated 20 July 2020
What this trial tests

trial testing Activity in Clinical Practice During the COVID-19 Crisis in 71 participants. Completed in 31 May 2020.

Timeline
15 March 2020
Primary endpoint
31 May 2020
31 May 2020

Quick facts

Lead sponsorCentre Hospitalier Universitaire de Nice
StatusCompleted
Study typeOBSERVATIONAL
Enrollment71
Start date15 March 2020
Primary completion31 May 2020
Estimated completion31 May 2020
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire de Nice

Who can join

Eligibility, any sex, with Clinical Practice During the COVID-19 Crisis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The infectivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), notably when handling human samples, remains poorly understood, as well as the impact of the COVID-19 pandemic in routine clinical and molecular pathology practice, and for personal working in pathology laboratories. This study evaluates the consequences of the COVID-19 crisis in clinical and molecular pathology laboratories in Europe mostly those orientated for diagnosis of thoracic diseases.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future.
    Hofman P, Ilié M, Chamorey E, Brest P, et al · · 2021 · cited 10× · PMID 33399086 · DOI 10.1016/j.esmoop.2020.100024

Verify or expand the search:

Other trials of Activity

Trials testing the same drug.

Other Centre Hospitalier Universitaire de Nice trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04476823.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing